Internal Medicine, Medical Oncology · Portland, OR
NPI
1447654470
Since 2014
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3303 S Bond Ave
Portland, OR, 97239
Phone (503) 494-6594
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
415 services
Medicare patients, 2024
160
Average age 74
Drug cost, 2024
$6.2M
1,342 prescriptions
Company payments, 2025
$105K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eleni Efstathiou was code 99213 (office e&m - established), 140 times for 79 patients. In total Eleni Efstathiou billed 415 services in 14 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 140 | 79 | $66.47 | $9,306 |
| 99214 Office E&M - Established | Office | 94 | 62 | $93.12 | $8,753 |
| 99215 Office E&M - Established | Office | 79 | 53 | $133.64 | $11K |
| 99205 Office E&M - New | Office | 33 | 33 | $158.17 | $5,219 |
| 99223 Hospital E&M - Initial | Facility | 19 | 13 | $137.95 | $2,621 |
| 99222 Hospital E&M - Initial | Facility | 12 | 11 | $104.46 | $1,253 |
By year: 2022 $55K for 410 services; 2023 $53K for 424 services; 2024 $40K for 415 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eleni Efstathiou prescribed most often to Medicare patients was Orgovyx (Relugolix), with 410 prescriptions and refills. In total Eleni Efstathiou wrote 1,342 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Orgovyx Relugolix | 410 | 415 | 62 | $1.1M |
| Nubeqa Darolutamide | 293 | 300 | 41 | $3.9M |
| Dexamethasone Generic | 85 | 92 | 23 | $629 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 82 | 155 | 24 | $840 |
| Atorvastatin Calcium Generic | 70 | 140 | 22 | $516 |
| Mounjaro Tirzepatide | 55 | 58 | Under 11 | $57K |
| Abiraterone Acetate Generic | 51 | 52 | 12 | $112K |
| Rosuvastatin Calcium Generic | 24 | 42 | Under 11 | $188 |
| Prednisone Generic | 19 | 24 | Under 11 | $93.22 |
| Erleada Apalutamide | 19 | 19 | Under 11 | $275K |
| Gabapentin Generic | 17 | 19 | Under 11 | $159 |
| Cabometyx Cabozantinib S-Malate | 15 | 15 | Under 11 | $384K |
| Ondansetron Odt Ondansetron | 14 | 14 | Under 11 | $230 |
| Sertraline Hcl Generic | 12 | 12 | Under 11 | $0 |
| Amlodipine Besylate Generic | 12 | 12 | Under 11 | $34.92 |
Brand drugs: 833 claims; generic drugs: 509 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eleni Efstathiou $105K ($105K in general payments such as food, travel and fees) from 10 companies. The largest payer was Pfizer Inc. with $52K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 20 | $52K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $14K |
| Tolmar, Inc. | 10 | $9,555 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $9,379 |
| pharmaand GmbH | 9 | $9,006 |
| AstraZeneca UK Limited AZN | 1 | $4,920 |
| Janssen Scientific Affairs, LLC JNJ | 2 | $2,368 |
| Merck Sharp & Dohme LLC MRK | 1 | $2,345 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $820 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.